ReviewAntonie van Leeuwenhoek2025
Paenibacillus peoriae: current knowledge and agricultural biotechnology potential of a close relative of P. polymyxa.
Review in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Integrative Exploration ofInternational journal of molecular sciences · 2026Article
- Response of triticale and its native rhizobacterial community to inoculation with a consortium of Paenibacillus sp. Z15 and Pseudomonas sp. KR227.World journal of microbiology & biotechnology · 2026Article
- Article
- Chloroflexota in agricultural soils: current knowledge and future research directions.Frontiers in microbiology · 2026Review
- Advances and Hotspots in Research on Verrucomicrobiota: Focus on Agroecosystems.Microbial ecology · 2025Review
- Pseudomonas protegens as a biocontrol agent against phytopathogenic fungi - mini review.World journal of microbiology & biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paenibacillus peoriae, a member of the genus Paenibacillus, is a gram-positive, spore-forming bacterium closely related to Paenibacillus polymyxa. This species exhibits a wide range of metabolic capabilities, enabling it to thrive in diverse environments and produce bioactive compounds with potential applications in agriculture and biotechnology. Recent studies reveal its capacity to produce biocontrol agents, such as fusaricidins, polymyxins, and tridecaptins, along with hydrolytic enzymes that inhibit phytopathogens including Fusarium, Rhizoctonia, Alternaria, Botrytis, Phytophthora (Oomycota phylum). Additionally, this species was capable of directly promoting plant growth through various mechanisms, such as the production of indole-3-acetic acid (IAA), nitrogen fixation, phosphorus solubilization, and 1-aminocyclopropane-1-carboxylic acid (ACC) deaminase activity. P. peoriae strains also produce enzymes like cellulase and protease, essential for various industrial applications, and extracellular polysaccharides (EPS) demonstrating potential in bioremediation and heavy metal removal. Recent studies highlight its ability to synthesize 2,3-butanediol, a valuable industrial compound, further establishing its biotechnological significance. This review consolidates current knowledge on the genome, metabolites, and applications of P. peoriae while identifying research gaps and future directions for maximizing its potential in sustainable agriculture and biotechnology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.